He was the only executive to do so before a Senate Health Committee hearing that also included the CEOs of Novo Nordisk and Sanofi.
You are here: Home / Eli Lilly CEO vows not to raise insulin prices again, while Novo Nordisk and Sanofi hedge
Market News and Views
He was the only executive to do so before a Senate Health Committee hearing that also included the CEOs of Novo Nordisk and Sanofi.